Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
American Society of Clinical Psychopharmacology (ASCP) 2019
May 28 - 31, 2019; Scottsdale, Arizona
May 28 - 31, 2019Scottsdale, Arizona
ASCP 2019Novel Convulsive Therapy May Cut Suicidal Thoughts in BDMagnetic seizure therapy appears effective in treating severe depression and suicidal thoughts while having a more benign effect on cognitive function than electroconvulsive therapy.
Medscape Medical News, June 4, 2019
ASCP 2019Cannabinoid May Boost Psychotherapy Efficacy in OCDAdding nabilone, a THC analogue and cannabinoid 1 receptor agonist, may enhance the effectiveness of exposure-based cognitive behavioral therapy in patients with severe obsessive compulsive disorder.
Medscape Medical News, June 3, 2019
ASCP 2019Botox May Help Bipolar Depression, Social AnxietyIn two small case series, injections of botulinum toxin into the glabellar region -- the area between the eyebrows and above the nose -- reduced symptoms of bipolar depression and social anxiety.
New Nonopioid Med Blunts Drug Withdrawal SymptomsLofexidine has been in use in the UK for more than 20 years and has shown efficacy in managing symptoms of severe opioid withdrawal.
It has now been approved in the US.
Medscape Medical News, Jun 01, 2018
MDMA-Assisted Psychotherapy Mitigates PTSD SymptomsPooled results from six double-blind, placebo-controlled phase 2 trials show benefit for adding MDMA, also known as ecstasy,
to psychotherapy for chronic posttraumatic stress disorder.
